doi: 10.1161/01.STR.0000176743.67564.5d
(Stroke. 2005;36:1627.)
© 2005 American Heart Association, Inc.
Original Contributions |
Effects of Acute Treatment With Pravastatin on Cerebral Vasospasm, Autoregulation, and Delayed Ischemic Deficits After Aneurysmal Subarachnoid Hemorrhage
A Phase II Randomized Placebo-Controlled Trial
From the Department of Neurosurgery, Addenbrooke’s Hospital, University of Cambridge, United Kingdom.
Reprint requests to Peter J. Kirkpatrick, FRCS, SN, Box 167, Level 4, Block A, University Department of Neurosurgery, Addenbrooke’s Hospital, Cambridge CB2 2QQ, United Kingdom. E-mail pjk21{at}medschl.cam.ac.uk
Background and Purpose— Statins may improve cerebral vasomotor reactivity through cholesterol-dependent and -independent mechanisms. A phase II randomized controlled trial was conducted to examine the hypothesis that acute pravastatin treatment could improve cerebrovascular autoregulation and reduce vasospasm-related complications after aneurysmal subarachnoid hemorrhage (SAH).
Methods— A total of 80 aneurysmal SAH (aSAH) patients (18 to 84 years of age) within 72 hours from the ictus were randomized equally to receive either oral pravastatin (40 mg) or placebo daily for up to 14 days. Primary end points were the incidence, duration, and severity of cerebral vasospasm, and duration of impaired autoregulation estimated from transcranial Doppler ultrasonography. Secondary end points were the incidence of vasospasm-related delayed ischemic deficits (DIDs) and disability at discharge.
Results— Prerandomization characteristics were balanced between the 2 groups. No treatment-related complication was observed. The incidences of vasospasm and severe vasospasm were reduced by 32% (P=0.006) and 42% (P=0.044), respectively, and the duration of severe vasospasm was shortened by 0.8 days (P=0.068) in the pravastatin group. These measurements were maximal on the ipsilateral side of ruptured aneurysms. The duration of impaired autoregulation was shortened bilaterally (P
0.01), and the incidence of vasospasm-related DIDs and mortality were decreased by 83% (P<0.001) and 75% (P=0.037), respectively, in the pravastatin group.
Conclusion— Acute treatment with pravastatin after aSAH is safe and ameliorates cerebral vasospasm, improves cerebral autoregulation, and reduces vasospasm-related DID. Unfavorable outcome at discharge was reduced primarily because of a reduction in overall mortality. This is the first demonstration of clinical benefits with immediate statin therapy for an acute cerebrovascular disorder.
Key Words: hemodynamics • ischemia • stain • subarachnoid hemorrhage • vasospasm
This article has been cited by other articles:
 |
|
 |
|
  V. Prinz and M. Endres The Acute (Cerebro)Vascular Effects of Statins Anesth. Analg., August 1, 2009; 109(2): 572 - 584. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Bederson, E. S. Connolly Jr, H. H. Batjer, R. G. Dacey, J. E. Dion, M. N. Diringer, J. E. Duldner Jr, R. E. Harbaugh, A. B. Patel, and R. H. Rosenwasser Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association Stroke, March 1, 2009; 40(3): 994 - 1025. [Full Text] [PDF]
|
|
|
|
|
|
A. M. Cook and E. A. Hessel II Meta-Analysis of Statins for Aneurysmal Subarachnoid Hemorrhage Falls Short Stroke, March 1, 2009; 40(3): e79 - e79. [Full Text] [PDF]
|
|
|
|
|
|
A. H. Kramer Statins in the Management of Aneurysmal Subarachnoid Hemorrhage--Not (Yet) a Standard of Care Stroke, March 1, 2009; 40(3): e80 - e81. [Full Text] [PDF]
|
|
|
|
|
|
S. H.-Y. Chou, E. E. Smith, N. Badjatia, R. G. Nogueira, J. R. Sims II, C. S. Ogilvy, G. A. Rordorf, and C. Ayata A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Simvastatin in Aneurysmal Subarachnoid Hemorrhage Stroke, October 1, 2008; 39(10): 2891 - 2893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. A.H. Sillberg, G. A. Wells, and J. J. Perry Do Statins Improve Outcomes and Reduce the Incidence of Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis Stroke, September 1, 2008; 39(9): 2622 - 2626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L Trimble and D. R Kockler Statin Treatment of Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage Ann. Pharmacother., December 1, 2007; 41(12): 2019 - 2023. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Zemke, M. U Farooq, A. Mohammed Yahia, and A. Majid Delayed ischemia after subarachnoid hemorrhage: result of vasospasm alone or a broader vasculopathy? Vascular Medicine, August 1, 2007; 12(3): 243 - 249. [Abstract] [PDF]
|
|
|
|
|
|
M.-Y. Tseng, P. J. Hutchinson, M. Czosnyka, H. Richards, J. D. Pickard, and P. J. Kirkpatrick Effects of Acute Pravastatin Treatment on Intensity of Rescue Therapy, Length of Inpatient Stay, and 6-Month Outcome in Patients After Aneurysmal Subarachnoid Hemorrhage Stroke, May 1, 2007; 38(5): 1545 - 1550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Moskowitz The 2006 Thomas Willis Lecture: The Adventures of a Translational Researcher in Stroke and Migraine Stroke, May 1, 2007; 38(5): 1645 - 1651. [Full Text] [PDF]
|
|
|
|
|
|
C. Dohmen, B. Bosche, R. Graf, T. Reithmeier, R.-I. Ernestus, G. Brinker, J. Sobesky, and W.-D. Heiss Identification and Clinical Impact of Impaired Cerebrovascular Autoregulation in Patients With Malignant Middle Cerebral Artery Infarction Stroke, January 1, 2007; 38(1): 56 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A M Naidech, J Drescher, P Tamul, A Shaibani, H H Batjer, and M J Alberts Acute physiological derangement is associated with early radiographic cerebral infarction after subarachnoid haemorrhage J. Neurol. Neurosurg. Psychiatry, December 1, 2006; 77(12): 1340 - 1344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Carod-Artal Statins and Cerebral Vasomotor Reactivity: Implications for a New Therapy? Stroke, October 1, 2006; 37(10): 2446 - 2448. [Full Text] [PDF]
|
|
|
|
|
|
M. Endres and U. Laufs Discontinuation of Statin Treatment in Stroke Patients Stroke, October 1, 2006; 37(10): 2640 - 2643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Rabinstein The blood and the vessel: Prediction of cerebral vasospasm after subarachnoid hemorrhage Neurology, March 14, 2006; 66(5): 622 - 623. [Full Text] [PDF]
|
|
|
|
|
|
G. K.C. Wong, W.S. Poon, M.-Y. Tseng, M. Czosnyka, H. Richards, J. D. Pickard, and P. J. Kirkpatrick Is There an Interaction Between Pravastatin and Clinical Events Other Than Vasospasm in Patients With Aneurysmal Subarachnoid Hemorrhage? * Response: Stroke, February 1, 2006; 37(2): 335 - 335. [Full Text] [PDF]
|
|
|
|
|
|
V. L. Feigin and M. Findlay Advances in Subarachnoid Hemorrhage Stroke, February 1, 2006; 37(2): 305 - 308. [Full Text] [PDF]
|
|
|
|
 |
|
 Does Acute Treatment with Pravastatin Reduce Complications After SAH? Journal Watch Neurology, December 8, 2005; 2005(1208): 5 - 5. [Full Text]
|
|